Silipos was listed on 05 August 2024 by the cicada3301 ransomware group (the group's claim; Ransomware Tracker by ExposureDrift has not confirmed a breach). cicada3301 listed 14 organizations that month and 72 in total.
- Listed 837 days ago.
- 473 organizations were listed by all groups in August 2024, see the month.
- 47 in Healthcare that month.
- 217 in US that month.
Updated 2026-11-19 06:28 UTC. Data: public leak-site listings. How we work.
Threat Group Post & Evidence
- Listed by
- Cicada3301 72 listings in total
The listing states no data size and no ransom demand.
No capture of the original post
We only show a screenshot when we captured the group's own page ourselves. For this listing we have not, so none is shown.
The group's leak-site address is on paid plans
Free accounts see who listed this organization, when, and what the post claims. The address of the group's own page is shown to license-key holders. If you have a key, see what a license key adds.
What the group says it holds
Taken from the group's own post. Ransomware Tracker by ExposureDrift has not seen the data and cannot confirm any of this.
Founded in 1989, Silipos is the global leader in gel technology across a wide range of industries including orthopedics, prosthetics, and skin care. Silipos is currently expanding with a broad range of lines from athletics to equestrian care. We manufacture over 300 products in Niagara Falls, N.Y. which are sold to over 7,000 customers in 90 countries worldwide. Our Niagara Falls production facility houses gel research and development, as well as base gel manufacturing and finished products conversion. Silipos is a leader in innovative gel manufacturing with unmatched product quality and healing properties. Silipos is committed to continually improving peoples’ lives with new and innovative gel solutions. Within the healthcare industry, Silipos is the most trusted source for medical gel solutions among healthcare professionals. We have built our reputation on innovation, quality, and out…
Show the full post (992 characters)
Founded in 1989, Silipos is the global leader in gel technology across a wide range of industries including orthopedics, prosthetics, and skin care. Silipos is currently expanding with a broad range of lines from athletics to equestrian care. We manufacture over 300 products in Niagara Falls, N.Y. which are sold to over 7,000 customers in 90 countries worldwide. Our Niagara Falls production facility houses gel research and development, as well as base gel manufacturing and finished products conversion. Silipos is a leader in innovative gel manufacturing with unmatched product quality and healing properties. Silipos is committed to continually improving peoples’ lives with new and innovative gel solutions. Within the healthcare industry, Silipos is the most trusted source for medical gel solutions among healthcare professionals. We have built our reputation on innovation, quality, and outstanding customer service. If companies do not contact us, the data will be published!
Amounts as written
- 7,000 customers
Kinds of data mentioned
-
Customer or client data
“We have built our reputation on innovation, quality, and outstanding customer service. If companies do not contact us, the data will be published!”
Plain-English summary AI-written
The group says it holds information about a company that manufactures gel products for industries including orthopedics, prosthetics, and skin care.
Written by an AI model (openai/gpt-6-luna) from the post above. It can contain mistakes: rely on the quote, not the summary.
What to do about this listing
Choose who you are. Each step shows why it appears and, where we have one, its source. General guidance, not legal or incident-response advice.
If you work with Silipos (customer, supplier or partner)
Within 3 days
- Do not open the group's page or download the data Do not visit the leak site or download files from a listing. Holding stolen data can be unlawful, and the files can carry malware. Wait for the company's own notice. Why: A safety rule for any leak listing.
- Ask Silipos directly Write to your contact and ask whether your data, or your access to their systems, is in scope, and ask for a written statement. Your contract or data-protection law may oblige them to tell you if your data is affected: check the notification clause. Why: A listing is only the group's claim; the company is the one who can confirm what was taken.
- Review what Silipos can reach of yours List the accounts, API keys, VPN or SSO connections and shared mailboxes this company has with you. Rotate the keys you gave them and remove access they do not need. Why: Access a supplier holds is how a listing about them can become a problem for you.
- Expect convincing phishing Messages that quote real orders, invoices or names are more likely after a leak. Tell finance and the help desk to treat any request from, or about, this company with extra care. Why: The post names: customer or client data.
Within 30 days
- Keep watching Silipos A supplier's listing can change after the first sighting: the group can add data, change the status or publish. Add the company to your supplier list to be told, and check your own domain too. Why: A listing is a moving claim, not a single event. Add to your supplier list Check your own domain
If you are Silipos
First 24 hours
- Reset credentials and sessions Force password, API-key and session-token resets for the accounts the post suggests were exposed, enforce phishing-resistant MFA, and revoke OAuth/SSO grants issued before the listing date. Why: The post names: customer or client data.
Within 3 days
- Size the exposure against your own systems Inventory which systems hold data of the kind and volume claimed, so notification and legal decisions rest on your records rather than the group's figures. Why: The post claims: 7,000 customers. Treat group figures as unverified.
- Lock down exposed admin, VPN and SSO panels Restrict by IP allow-list or a zero-trust proxy and require MFA. Why: A passive scan found 1 critical panel(s) reachable from the internet.
- Check regulatory and stakeholder notification duties United States: state breach-notification laws apply; listed companies may also have SEC Form 8-K Item 1.05 duties for material incidents, and HIPAA applies to health data. Health data adds sector rules. This is general guidance, not legal advice: confirm current rules with counsel. Why: Listing country: United States.
General readiness for any ransomware claim (not about this listing)
- Offline, immutable backups and a restore drill Keep backups outside domain-admin reach and practise a restore; a leak does not remove the risk of re-encryption. Why: General practice for any ransomware claim; not specific to this listing.
- Look for mass file access and unusual outbound transfers Review EDR, proxy and identity logs for bulk reads, archive creation and large uploads to file-sharing services. Why: General practice for any ransomware claim; not specific to this listing.
- Phishing-resistant MFA on remote access Enforce MFA on VPN, SSO and admin panels, and retire password-only or SMS-based remote access. Why: General practice for any ransomware claim; not specific to this listing.
Listing details
Listing severity score (heuristic)
81/100 • CRITICALA heuristic built from sector, group, data volume and claim details. It is not evidence that a breach occurred or a measure of harm.
External Attack Surface Profile
ASM IntelligenceRun a free passive scan on your own domain to see what an attacker can see from the outside.